Avivagen Stock Net Income
| VIVXF Stock | USD 0.0001 0.00 0.00% |
Avivagen fundamentals help investors to digest information that contributes to Avivagen's financial success or failures. It also enables traders to predict the movement of Avivagen Pink Sheet. The fundamental analysis module provides a way to measure Avivagen's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Avivagen pink sheet.
Avivagen |
Avivagen Company Net Income Analysis
Avivagen's Net income is the profit of a company for the reporting period, which is derived after taking revenues and gains and subtracting all expenses and losses. Net income is one of the most-watched numbers by money managers as well as individual investors.
Current Avivagen Net Income | (6.39 M) |
Most of Avivagen's fundamental indicators, such as Net Income, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Avivagen is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Because income is reported on the Income Statement of a company and is measured in dollars some investors prefer to use Profit Margin, which measures income as a percentage of sales.
| Competition |
Based on the recorded statements, Avivagen reported net income of (6.39 Million). This is 101.87% lower than that of the Healthcare sector and significantly lower than that of the Drug Manufacturers—Specialty & Generic industry. The net income for all United States stocks is 101.12% higher than that of the company.
Avivagen Net Income Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Avivagen's direct or indirect competition against its Net Income to detect undervalued stocks with similar characteristics or determine the pink sheets which would be a good addition to a portfolio. Peer analysis of Avivagen could also be used in its relative valuation, which is a method of valuing Avivagen by comparing valuation metrics of similar companies.Avivagen is currently under evaluation in net income category among its peers.
Avivagen Fundamentals
| Return On Asset | -0.95 | |||
| Operating Margin | (12.34) % | |||
| Current Valuation | 9.01 M | |||
| Shares Outstanding | 77.19 M | |||
| Shares Owned By Insiders | 1.43 % | |||
| Price To Sales | 11.96 X | |||
| Revenue | 1.3 M | |||
| Gross Profit | 534.34 K | |||
| EBITDA | (4.68 M) | |||
| Net Income | (6.39 M) | |||
| Cash And Equivalents | 494.81 K | |||
| Cash Per Share | 0.01 X | |||
| Total Debt | 1.4 M | |||
| Current Ratio | 0.81 X | |||
| Book Value Per Share | (0.07) X | |||
| Cash Flow From Operations | (4.6 M) | |||
| Earnings Per Share | (0.08) X | |||
| Number Of Employees | 13 | |||
| Beta | 0.74 | |||
| Market Capitalization | 5.2 M | |||
| Total Asset | 3.48 M | |||
| Z Score | -1.5 | |||
| Net Asset | 3.48 M |
About Avivagen Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Avivagen's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Avivagen using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Avivagen based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Currently Active Assets on Macroaxis
Other Information on Investing in Avivagen Pink Sheet
Avivagen financial ratios help investors to determine whether Avivagen Pink Sheet is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Avivagen with respect to the benefits of owning Avivagen security.